FDA Approves Another Drug for Schizophrenia and Bipolar I Disorder
For the management of schizophrenia and bipolar I disorder, US FDA recently approved a once-daily oral combination medication of olanzapine and samidorphan. Olanzapine on its own is highly efficacious but demonstrates side effects such as weight gain. In the ENLIGHTEN-2 study, the combination has proven its efficacy along with significantly less weight gain than olanzapine […]